Spark Investment Management LLC Uro Gen Pharma Ltd. Transaction History

Spark Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 10, 2018	SELL	$38.64 - $57.54 $2.73 Million - $4.07 Million	-70,700 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$27.28 - $43.26 $916,608 - $1.45 Million	33,600 Added 90.57%	70,700 $2.63 Million
Q3 2017 Nov 13, 2017	BUY	$17.15 - $32.72 $636,265 - $1.21 Million	37,100	37,100 $1.17 Million

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.